Arches. Photo by Daniel Chia
HOPES: Huntington's Outreach Project for Education, at Stanford
Feb
08
2011

riluzole

A drug that has been shown to have energy buffering and anti-glutamate properties. After failing a phase III clinical trial, riluzole is no longer being studied as a treatment for HD.